secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGILE THERAPEUTICS INC (—)
CIK:        0001261249
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0001558370-23-010792
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Agile Therapeutics gets Nasdaq extension to Sept 25, 2023; must meet $2.5M equity rule
--------------------------------------------------------------------------------

- Received 180-day extension from Nasdaq; must regain compliance with $2.5M stockholders' equity by Sept 25, 2023.
- Reported stockholders' equity of ($5.545M) as of Dec 31, 2022, below requirement.
- Failure to demonstrate compliance by Sept 25 may lead to delisting; company intends to take measures.
- Delisting could reduce liquidity, market price, and access to equity markets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1261249/000155837023010792/0001558370-23-010792-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1261249/000155837023010792/agrx-20230602x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-010792

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer